M&A Activity • Apr 7, 2022
M&A Activity
Open in ViewerOpens in native device viewer


| Informazione Regolamentata n. 20153-10-2022 |
Data/Ora Ricezione 07 Aprile 2022 21:44:33 |
Euronext Growth Milan | |
|---|---|---|---|
| Societa' | : | MAPS | |
| Identificativo Informazione Regolamentata |
: | 160074 | |
| Nome utilizzatore | : | MAPSN03 - Ciscato | |
| Tipologia | : | REGEM; 3.1 | |
| Data/Ora Ricezione | : | 07 Aprile 2022 21:44:33 | |
| Data/Ora Inizio Diffusione presunta |
: | 07 Aprile 2022 21:44:34 | |
| Oggetto | : | MAPS: MERGER BY INCORPORATION OF MAPS HEALTHCARE INTO ARTEXE |
|
| Testo del comunicato |
Vedi allegato.


MAPS (MAPS:IM; IT0005364333), Innovative SME listed on Euronext Growth Milan operating in the digital transformation sector, following up on what was communicated on 30 November 2021, 21 December 2021 and 25 December 2021 announces that today the merger deed by incorporation of Maps Healthcare S.r.l. (hereinafter referred to as "Maps Healthcare" or "Merged Company") into Artexe S.p.A. (hereinafter referred to as "Artexe" or "Merging Company") has been concluded.
The merger deed will be registered with the competent Companies House within the legal term of 30 days from today; notice will be given to the market in due time.
For a more detailed description of the merger terms, please refer to the aforementioned press release and to the other documents available to the public at the company's registered office and on the website www.mapsgroup.it, section Investors/Mergers.
Founded in 2002, MAPS is an Innovative SME operating in the digital transformation sector. With its registered office in Parma and with approximately 200 employees, it produces and distributes software for the analysis of big data that allows client companies to manage and analyse large quantities of data and information, helping them make strategic and operational decisions and define new business models. It operates in a context characterised by high growth potential: the global market for digital transformation technologies reached \$1,100 billion in 2018; in 2020, a market of \$1,600 billion is estimated (CAGR 2018-2020 approximately +20%). MAPS operates through 3 business units (Large Enterprise, Healthcare Industry, Gzoom) and has a portfolio of over 400 highly loyal Customers from different markets: Telco, Utilities, Healthcare, Retail, Industry and Public Administration.
Through the Patient Journey line of products, it is a leader in the sector of patient reception in healthcare facilities, presiding over the market with over 1,300 installations, which manage the access paths of over 20 million patients nationwide. The Group invests constantly in R&D. The Research & Solutions division, established in 2016, is responsible for identifying market needs and developing software solutions.
The Group closed 2020 with consolidated revenues of Euro 17.9 million and an EBITDA of Euro 3.4 million. In the last 3 years, MAPS has tripled revenue from proprietary solutions and more than doubled EBITDA. The company is characterised by high levels of recurring revenues: recurring fee revenues represent 28% of consolidated operating revenues in 2020. The Group's organic growth has been accompanied by a significant M&A activity, with the acquisition of IG Consulting (2011), Artexe (2018), Roialty (2019), SCS Computers (2020) and IASI (2021).
Release available on and on www.mapsgroup.it
MAPS T +390521052300 [email protected]
Marco Ciscato – Investor Relations Manager [email protected]
EURONEXT GROWTH ADVISOR BPER Banca | T +390272 74 92 29 [email protected]
INVESTOR RELATIONS & FINANCIAL MEDIA IR Top Consulting | T +390245473884 Maria Antonietta Pireddu, [email protected] Domenico Gentile, [email protected] │ Antonio Buozzi, [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.